-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

113. Hemoglobinopathies, Excluding Thalassemia—Basic and Translational Science: Poster III

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Adult, Anemias, sickle cell disease, Animal models, bioengineering, Diseases, Non-Biological, sickle cell trait, thalassemia, Therapies, Adverse Events, cellular interactions, Genetic Disorders, Biological Processes, Hemoglobinopathies, Technology and Procedures, Cell Lineage, erythropoiesis, Study Population, Clinically relevant, genomics, pharmacology, immune mechanism, inflammation, iron metabolism, molecular interactions, RNA sequencing, pathogenesis, pathways, senescence, signal transduction
Monday, December 7, 2020: 7:00 AM-3:30 PM

Dipti Gupta1,2, Samuel Lessard, PhD1*, Shujia Dai3*, Yukio Nakamura, MD, PhD4*, Alexandra Hicks, PhD1*, Thomas K Harris, PhD5* and Sriram Krishnamoorthy, PhD1

1Rare Blood Disorders, Sanofi, Waltham, MA
2Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, FL
3Biochemistry and Bioanalytics, Translational Science, Sanofi, Cambridge, MA
4Cell Engineering Division, RIKEN BioResource Research Center, Tsukuba, Japan
5Department of Biochemistry and Molecular Biology, University of Miami, Miller School of Medicine, Miami, FL

Thomas Gentinetta, PhD1*, Gregory M. Vercellotti, MD2, Chunsheng Chen2*, Julia Nguyen2*, Fuad Abdulla2*, Ping Zhang, PhD2*, Gregory J Kato, MD3, Nathan Brinkman, PhD4*, Adrian Zuercher, PhD1* and John D Belcher, PhD5

1Research and Development, CSL Behring AG, Bern, Switzerland
2Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota Medical School, Minneapolis, MN
3Clinical Research & Development, CSL Behring, King of Prussia
4Research & Development, CSL Behring, Kankakee, IL
5Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN

Yuncheng Man1*, Debnath Maji, PhD1*, Ran An, PhD1, Sanjay P Ahuja, MD2, Jane A. Little, MD3, Pedram Mohseni, PhD1*, Michael A Suster, PhD1* and Umut A. Gurkan, PhD1

1Case Western Reserve University, Cleveland, OH
2University Hospitals Cleveland Medical Center, Rainbow Babies and Children's Hospital, Cleveland, OH
3University of North Carolina at Chapel Hill, Chapel Hill, NC

Maliha Maryam Ahmad, BS1*, Laxminath Tumburu, PhD2*, Chunyu Liu, PhD3*, Mehdi Pirooznia, MD, PhD4* and Swee Lay Thein, DSc, FRCP, MBBS, MRCP2

1Sickle Cell Branch, NHLBI, National Institutes of Health, Alexandria, VA
2Sickle Cell Branch, NHLBI, National Institutes of Health, Bethesda, MD
3Department of Biostatistics, Boston University, Boston, MA
4Bioinformatics and Computational Biology Laboratory, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Billy Stuart*, Peter Rahl*, Kingsley Appiah*, Ivan Efremov*, Lorin Thompson*, Owen Wallace* and Christopher Moxham*

Fulcrum Therapeutics, Cambridge, MA

Yankai Zhang, PhD1, Celeste K. Kanne, BA1*, Jennifer N. Tran, DO1, Michael J. Lacagnina, PhD2*, Peter M. Grace, PhD2*, Mark J. Burish, MD, PhD3* and Vivien A. Sheehan, MD, PhD1

1Department of Pediatrics, Division of Hematology/Oncology, Baylor College of Medicine, Houston, TX
2The University of Texas MD Anderson Cancer Center, Houston, TX
3The University of Texas Health Science Center, Houston, TX

Jen Judy, PhD, MS1*, Xunde Wang, PhD2*, Fayaz Seifuddin, PhD3*, Laxminath Tumburu, PhD2*, Mehdi Pirooznia, MD, PhD3* and Swee Lay Thein, DSc, FRCP, MBBS, MRCP2

1National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
2Sickle Cell Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
3Bioinformatics and Computational Biology Laboratory, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Christopher M Ventura, Ph.D.1*, Stacy B Kiven, BS2*, Nils Lambrecht, MD, PhD3,4* and Kalpna Gupta, PhD5

1Department of Medicine- Hematology/Oncology, University of California, Irvine, Irvine, CA
2Division of Hematology/Oncology, Southern California Institute for Research and Education, VA Medical Center, University of California Irvine, Long Beach, CA
3VA Long Beach Health Care System, Long Beach, CA
4VA Long Beach Medical Center, Long Beach, CA
5Division of Hematology/Oncology, Department of Medicine, University of California, Irvine, Irvine, CA

Madhav Vissa1,2, Eric Soupene, PhD1,2*, Sandra K. Larkin, MS1,2*, Lynne D. Neumayr, MD1,2, Elliott P. Vichinsky, MD1,2 and Frans A. Kuypers, PhD1,2*

1UCSF Benioff Children's Hospital Oakland, Oakland, CA
2Children's Hospital Oakland Research Institute, Oakland, CA

Sharjeel Syed1*, Jihad Aljabban, MMSc, MD2, Jonathan Trujillo, MD, PhD3, Saad Syed, BS4*, Robert Cameron, MD, PhD5*, Maryam Panahiazar, PhD6* and Dexter Hadley, MD, PhD6*

1Univeristy of Chicago Hospital, Chicago
2University of Wisconsin Hospital and Clinics, Madison
3Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, Chicago, IL
4Stanford University School of Medicine, Stanford, CA
5University of Chicago Hospitals, Chicago
6University of California San Francisco, San Francisco, CA

Ravi Vats, MSc1, Enrico M Novelli, M.D., M.S.2, Mark T. Gladwin, MD3, Prithu Sundd, PhD1 and Tirthadipa Pradhan4

1Pittsburgh Heart, Lung and Blood Vascular Medicine Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA
2Heart, Lung and Blood Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, PA
3University of Pittsburgh, Pittsburgh, PA
4University of Pittsburgh, Pittsburgh

*signifies non-member of ASH